Literature DB >> 20159969

A novel role for protein inhibitor of activated STAT (PIAS) proteins in modulating the activity of Zimp7, a novel PIAS-like protein, in androgen receptor-mediated transcription.

Yue Peng1, Jane Lee, Chunfang Zhu, Zijie Sun.   

Abstract

The PIAS proteins (protein inhibitor of activated STAT) were originally identified as inhibitors of the JAK-STAT pathway. Subsequently, their roles on transcriptional regulation have been identified in modulation of the androgen receptor (AR) and other nuclear hormone receptor-mediated actions. Zimp7, also named Zmiz2, is a novel PIAS-like protein and functions as a transcriptional co-activator. In this study, we demonstrate an interaction between Zimp7 and PIAS proteins with higher preference for PIAS3. A modified mammalian one-hybrid assay showed that the NH(2)-terminal proline-rich domain of Zimp7 and the region spanning amino acids 321-486 of PIAS3 were the primary interaction segments. The interaction between Zimp7 and PIAS3 proteins was further confirmed by in vitro protein pull-down and co-immunoprecipitation assays with both exogenous and endogenous proteins. Expression of exogenous PIAS3 further enhances Zimp7-mediated augmentation of AR transcription. Knockdown of the endogenous PIAS3 protein using a specific PIAS3 small hairpin RNA reduced the augmentation of Zimp7 on AR-mediated transcription. Co-localization of Zimp7 and PIAS3 proteins was observed in the nuclei of cells by immunostaining. Exogenous PIAS3 expression enhances the stability of the Zimp7 protein. Using chromatin immunoprecipitation assays, we showed that PIAS3 is involved in the AR- and Zimp7-formed protein complex(es) in the AR downstream target promoter to facilitate androgen-induced transcription. Finally, we further demonstrated that loss of Zimp7 significantly impaired PIAS3-mediated enhancement on AR activity in mouse Zimp7 null (zimp7(-/-)) embryonic fibroblasts. Taken together, these results demonstrate a novel interaction between PIAS and PIAS-like proteins and elucidate a novel regulatory mechanism for PIAS proteins in AR-mediated transcription.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20159969      PMCID: PMC2857025          DOI: 10.1074/jbc.M109.079327

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Modulation of STAT signaling by STAT-interacting proteins.

Authors:  K Shuai
Journal:  Oncogene       Date:  2000-05-15       Impact factor: 9.867

Review 2.  A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases.

Authors:  P K Jackson
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

3.  The Drosophila trithorax group gene tonalli (tna) interacts genetically with the Brahma remodeling complex and encodes an SP-RING finger protein.

Authors:  Luis Gutiérrez; Mario Zurita; James A Kennison; Martha Vázquez
Journal:  Development       Date:  2003-01       Impact factor: 6.868

4.  PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases.

Authors:  Noora Kotaja; Ulla Karvonen; Olli A Jänne; Jorma J Palvimo
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

Review 5.  PIAS proteins and transcriptional regulation--more than just SUMO E3 ligases?

Authors:  Andrew D Sharrocks
Journal:  Genes Dev       Date:  2006-04-01       Impact factor: 11.361

6.  DJ-1 positively regulates the androgen receptor by impairing the binding of PIASx alpha to the receptor.

Authors:  K Takahashi; T Taira; T Niki; C Seino; S M Iguchi-Ariga; H Ariga
Journal:  J Biol Chem       Date:  2001-07-26       Impact factor: 5.157

7.  Two androgen response regions cooperate in steroid hormone regulated activity of the prostate-specific antigen promoter.

Authors:  K B Cleutjens; C C van Eekelen; H A van der Korput; A O Brinkmann; J Trapman
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

8.  ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation.

Authors:  N Kotaja; S Aittomäki; O Silvennoinen; J J Palvimo; O A Jänne
Journal:  Mol Endocrinol       Date:  2000-12

9.  Identification and characterization of a functional promoter region in the human eosinophil IL-5 receptor alpha subunit gene.

Authors:  Z Sun; D A Yergeau; T Tuypens; J Tavernier; C C Paul; M A Baumann; D G Tenen; S J Ackerman
Journal:  J Biol Chem       Date:  1995-01-20       Impact factor: 5.157

10.  The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor.

Authors:  Jane Lee; Jason Beliakoff; Zijie Sun
Journal:  Nucleic Acids Res       Date:  2007-06-21       Impact factor: 16.971

View more
  10 in total

1.  The beta-catenin binding protein ICAT modulates androgen receptor activity.

Authors:  Ming Zhuo; Chunfang Zhu; JingLucy Sun; William I Weis; Zijie Sun
Journal:  Mol Endocrinol       Date:  2011-09-01

2.  Identification of a novel role of ZMIZ2 protein in regulating the activity of the Wnt/β-catenin signaling pathway.

Authors:  Suk Hyung Lee; Chunfang Zhu; Yue Peng; Daniel T Johnson; Lynn Lehmann; Zijie Sun
Journal:  J Biol Chem       Date:  2013-10-30       Impact factor: 5.157

3.  The leucine zipper putative tumor suppressor 2 protein LZTS2 regulates kidney development.

Authors:  Yue Peng; Curtis Clark; Richard Luong; William H Tu; Jane Lee; Daniel T Johnson; Amrita Das; Thomas J Carroll; Zijie Sun
Journal:  J Biol Chem       Date:  2011-09-26       Impact factor: 5.157

4.  PIAS4 is associated with macro/microcephaly in the novel interstitial 19p13.3 microdeletion/microduplication syndrome.

Authors:  Julián Nevado; Jill A Rosenfeld; Rocío Mena; María Palomares-Bralo; Elena Vallespín; María Ángeles Mori; Jair A Tenorio; Karen W Gripp; Elizabeth Denenberg; Miguel Del Campo; Alberto Plaja; Rubén Martín-Arenas; Fernando Santos-Simarro; Lluis Armengol; Gordon Gowans; María Orera; M Carmen Sanchez-Hombre; Esther Corbacho-Fernández; Alberto Fernández-Jaén; Chad Haldeman-Englert; Sulagna Saitta; Holly Dubbs; Duban B Bénédicte; Xia Li; Lani Devaney; Mary Beth Dinulos; Stephanie Vallee; M Carmen Crespo; Blanca Fernández; Victoria E Fernández-Montaño; Inmaculada Rueda-Arenas; María Luisa de Torres; Jay W Ellison; Salmo Raskin; Carlos A Venegas-Vega; Fernando Fernández-Ramírez; Alicia Delicado; Sixto García-Miñaúr; Pablo Lapunzina
Journal:  Eur J Hum Genet       Date:  2015-04-08       Impact factor: 4.246

5.  Deletion of leucine zipper tumor suppressor 2 (Lzts2) increases susceptibility to tumor development.

Authors:  Daniel T Johnson; Richard Luong; Suk Hyung Lee; Yue Peng; Atossa Shaltouki; Jane T Lee; Dong Lin; Yuzhuo Wang; Zijie Sun
Journal:  J Biol Chem       Date:  2012-12-28       Impact factor: 5.157

6.  Convergence of the ZMIZ1 and NOTCH1 pathways at C-MYC in acute T lymphoblastic leukemias.

Authors:  Lesley A Rakowski; Derek D Garagiola; Choi M Li; Margaret Decker; Sarah Caruso; Morgan Jones; Rork Kuick; Tomasz Cierpicki; Ivan Maillard; Mark Y Chiang
Journal:  Cancer Res       Date:  2012-11-16       Impact factor: 12.701

7.  Identification of a Radiosensitivity Molecular Signature Induced by Enzalutamide in Hormone-sensitive and Hormone-resistant Prostate Cancer Cells.

Authors:  Maryam Ghashghaei; Tamim M Niazi; Adriana Aguilar-Mahecha; Kathleen Oros Klein; Celia M T Greenwood; Mark Basik; Thierry M Muanza
Journal:  Sci Rep       Date:  2019-06-20       Impact factor: 4.379

8.  Circulating Tumor Cell-Free DNA Genes as Prognostic Gene Signature for Platinum Resistant Ovarian Cancer Diagnosis.

Authors:  Camille C Gunderson; Rangasudhagar Radhakrishnan; Rohini Gomathinayagam; Sanam Husain; Sheeja Aravindan; Kathleen M Moore; Danny N Dhanasekaran; Muralidharan Jayaraman
Journal:  Biomark Insights       Date:  2022-03-28

9.  ZMIZ2 promotes the development of triple-receptor negative breast cancer.

Authors:  Xiaopan Zou; Yan Liu; Jun Di; Wei Wei; Nobumoto Watanabe; Jiang Li; Xiaomeng Li
Journal:  Cancer Cell Int       Date:  2022-01-31       Impact factor: 5.722

10.  Platelet-Related Variants Identified by Exomechip Meta-analysis in 157,293 Individuals.

Authors:  John D Eicher; Nathalie Chami; Tim Kacprowski; Akihiro Nomura; Ming-Huei Chen; Lisa R Yanek; Salman M Tajuddin; Ursula M Schick; Andrew J Slater; Nathan Pankratz; Linda Polfus; Claudia Schurmann; Ayush Giri; Jennifer A Brody; Leslie A Lange; Ani Manichaikul; W David Hill; Raha Pazoki; Paul Elliot; Evangelos Evangelou; Ioanna Tzoulaki; He Gao; Anne-Claire Vergnaud; Rasika A Mathias; Diane M Becker; Lewis C Becker; Amber Burt; David R Crosslin; Leo-Pekka Lyytikäinen; Kjell Nikus; Jussi Hernesniemi; Mika Kähönen; Emma Raitoharju; Nina Mononen; Olli T Raitakari; Terho Lehtimäki; Mary Cushman; Neil A Zakai; Deborah A Nickerson; Laura M Raffield; Rakale Quarells; Cristen J Willer; Gina M Peloso; Goncalo R Abecasis; Dajiang J Liu; Panos Deloukas; Nilesh J Samani; Heribert Schunkert; Jeanette Erdmann; Myriam Fornage; Melissa Richard; Jean-Claude Tardif; John D Rioux; Marie-Pierre Dube; Simon de Denus; Yingchang Lu; Erwin P Bottinger; Ruth J F Loos; Albert Vernon Smith; Tamara B Harris; Lenore J Launer; Vilmundur Gudnason; Digna R Velez Edwards; Eric S Torstenson; Yongmei Liu; Russell P Tracy; Jerome I Rotter; Stephen S Rich; Heather M Highland; Eric Boerwinkle; Jin Li; Ethan Lange; James G Wilson; Evelin Mihailov; Reedik Mägi; Joel Hirschhorn; Andres Metspalu; Tõnu Esko; Caterina Vacchi-Suzzi; Mike A Nalls; Alan B Zonderman; Michele K Evans; Gunnar Engström; Marju Orho-Melander; Olle Melander; Michelle L O'Donoghue; Dawn M Waterworth; Lars Wallentin; Harvey D White; James S Floyd; Traci M Bartz; Kenneth M Rice; Bruce M Psaty; J M Starr; David C M Liewald; Caroline Hayward; Ian J Deary; Andreas Greinacher; Uwe Völker; Thomas Thiele; Henry Völzke; Frank J A van Rooij; André G Uitterlinden; Oscar H Franco; Abbas Dehghan; Todd L Edwards; Santhi K Ganesh; Sekar Kathiresan; Nauder Faraday; Paul L Auer; Alex P Reiner; Guillaume Lettre; Andrew D Johnson
Journal:  Am J Hum Genet       Date:  2016-06-23       Impact factor: 11.043

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.